Biohaven BHVN Return on invested capital

Return on invested capital at other companies

Eli LillyLLY

39.7%+10.3pp

Xenon PharmaceuticalsXENE

-54%+2.2pp

Rapport Therapeutics, Inc.RAPP

-52.1%+9.1pp

Vir Biotechnology, Inc.VIR

-36.6%-10.5pp

Monte Rosa Therapeutics, Inc.GLUE

-53.9%—

Avalo TherapeuticsAVTX

-42.9%—

FAQ

What is Biohaven's return on invested capital?

Biohaven (BHVN) reported return on invested capital of -395.4% in Q1 2026.

How has Biohaven's return on invested capital changed year-over-year?

Biohaven's return on invested capital increased by 27.8% year-over-year, from -547.4% to -395.4%.

What is the long-term trend for Biohaven's return on invested capital?

Over 2 years (2023 to 2025), Biohaven's return on invested capital has grown at a 41.0% compound annual growth rate (CAGR), from -162.6% to -323.1%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.